Business Wire

Thales Wins Google Cloud Technology Partner of the Year Security – Data Protection Award

Share

Thales has been selected as the Google Cloud Technology Partner of the Year in the Security – Data Protection category. Thales was selected alongside a global field of top Google Cloud partners for excellence in developing and implementing customer solutions based on Google Cloud’s technology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230829348216/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

©Thales

The Thales and Google Cloud collaboration addresses the needs of organizations around the world that are facing ever-increasing security, sovereignty, and performance requirements for their cloud deployments. With many years of cybersecurity expertise, Thales provides the level of trust and security required for customers around the world to move to the cloud, while maintaining the necessary level of control. By combining Thales’ platform expertise with Google Cloud’s enterprise-grade solutions and cutting-edge infrastructure, the two companies work closely on a number of broad data security initiatives.

Thales, in its constant search of excellence in its security portfolio, recently announced a new collaboration to develop data security capabilities and bring additional AI-powered features to users of its CipherTrust Data Security platform. This is powered by Google Cloud’s Vertex AI machine learning capabilities, to discover, classify and protect sensitive data in the cloud. The machine learning functionality helps to automate fundamental tasks for customers and ensure their sensitive cloud-hosted data remains protected.

Since late 2022, Thales’ CipherTrust Cloud Key Manager has also supported Bring Your Own Key (BYOK) initiatives, including those for Google Cloud and Google Workspace. Thales and Google Cloud have also collaborated to operate a sovereign cloud joint venture (S3NS) for Google Cloud customers in France who seek to meet stringent data sovereignty requirements, such as those applicable to state and critical infrastructure organizations.

Thales has built a structured cloud offering for companies that want to meet the most demanding data protection standards. In France, S3NS, the joint venture between Thales and Google Cloud, aims to offer French companies and public institutions a solution providing the equivalent of Google Cloud , compliant with the “SecNumCloud” label, a certification from the French information systems security agency (ANSSI). To date, SecNumCloud has the highest level of protection in France, excluding the protection of national defense secrets, and in Europe. S3NS has a first offering already available that offers additional guarantees & controls, such as data location in Europe and external encryption managed by S3NS (based on Thales technology).

“Google Cloud’s partner awards recognize the significant impact and customer success that our partners have driven over the past year," said Kevin Ichhpurani, Corporate Vice President, Global Ecosystem and Channels at Google Cloud. "We're delighted to recognize Thales as a 2023 Google Cloud Partner Award winner, and look forward to a continued strong partnership in support of our mutual customers."

Sebastien Cano, Senior Vice President of Cloud Protection and Licensing activities at Thales, commented: “We are very proud of our ongoing relationship with Google Cloud and this latest award recognises the brilliant work we’ve been doing with them across a range of projects. Together we are helping customers around the world discover, classify and protect their data more efficiently, and ensure their move to the cloud is as secure and compliant as possible.”

Thales is also participating at Google Cloud Next, which is taking place from 29-31 August 2023. Some of the sessions include:

How global leaders are addressing digital sovereignty requirements, with Cyprien Falque, CEO of S3NS More details about the event, which will be available to watch both live and on-demand online, can be found here.

About Thales

Thales (Euronext Paris: HO) is a global leader in advanced technologies within three domains: Defence & Security, Aeronautics & Space, and Digital Identity & Security. It develops products and solutions that help make the world safer, greener and more inclusive.

 

The Group invests close to €4 billion a year in Research & Development, particularly in key areas such as quantum technologies, Edge computing, 6G and cybersecurity.

 

Thales has 77,000 employees in 68 countries. In 2022, the Group generated sales of €17.6 billion.

 

PLEASE VISIT

Thales Group
Cloud Protection & Licensing Solutions | Thales Group

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PRESS CONTACT
Thales, Media Relations
Security & Cybersecurity
Marion Bonnet
+33 (0)6 60 38 48 92
marion.bonnet@thalesgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Aspect Announces CEO Leadership Transition and New Independent Board7.1.2026 01:13:00 EET | Press release

Aspect, a leading provider of cloud-based workforce management solutions, has announced a leadership transition, including the appointment of Jeff Kupietzky as Interim Chief Executive Officer and the formation of a new independent Board of Directors, marking an important next chapter for the company. As part of this transition, Darryl Kelly will step down as Chief Executive Officer and transition into a Strategic Advisor role, effective January 1, 2026. Darryl led Aspect through a pivotal period of transformation, helping reposition the business, refine its vision, and reinvigorate its innovation and execution. The company and its stakeholders thank Darryl for his leadership and contributions during a period of meaningful change. With Darryl continuing as Strategic Advisor, the organization retains continuity for employees, customers, and stakeholders. “Aspect is starting a new season, building upon the strong foundation we’ve created together,” said Darryl Kelly. “This transition is a

Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of First-In-Human Study for STC-1010 in Unresectable Metastatic Stage Colorectal Cancer (MSS CRC) Patients6.1.2026 22:00:00 EET | Press release

Brenus Pharma, a clinical stage biotechnology company unlocking the immune system in vivo to fight solid tumors, announced the successful completion of the first dose levels in its ongoing first-in-human study. The multi-center, open-label trial (NCT06934538) is a phase Ia/Ib study designed to evaluate safety, tolerability and preliminary clinical activity of STC-10101 in a first line setting. It will include in vivo analysis of immune and tumor dynamics during dose escalation of treatment and cohort extension to patients with unresectable locally advanced (stage IIIC, T4b) or unresectable metastatic (stage IV) MSS2 colorectal cancer (CRC). Early findings indicate that the first dose levels have been successfully completed with good overall tolerance and no-dose-limiting toxicities observed to date. “We are pleased to report that the safety profile observed to date is good and consistent with our expectations with no DLT,” said Paul Bravetti, CEO of Brenus Pharma. “Moreover, preliminar

SPIE, the International Society for Optics and Photonics, Announces Its 2026 Fellows6.1.2026 21:35:00 EET | Press release

SPIE, the international society for optics and photonics, welcomes 40 Members as new Fellows of the Society in the 2026 cohort. They join their Fellow Member colleagues in being honored for their excellent technical achievements, as well as for their substantial service to the optics and photonics community and to SPIE. Fellows are Members of the Society who have made significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and imaging. Since the Society's inception in 1955, more than 1,800 SPIE Members have become Fellows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106630672/en/ SPIE, the international society for optics and photonics, announces its 2026 Fellows This year’s inductees are high-profile leaders in academia, industry, and government, many of whom are particularly prominent in their support of the optics and photonics community and mentorship of others. “It’

Chemelex Adds Electric Heat Trace Group Ltd.’s SmartTrace Monitoring Platform to its Heat Tracing Portfolio6.1.2026 21:00:00 EET | Press release

Chemelex, a global leader in electric thermal and sensing solutions, today announced the successful completion of its acquisition of substantially all the assets and ongoing operations of Electric Heat Trace Group Ltd. (EHT Group), headquartered in Ontario, Canada. This strategic move marks an exciting start to the new year and reinforces Chemelex’s commitment to delivering smarter, data-driven solutions for industrial heat trace systems. EHT Group is a recognized innovator in heat trace management, offering advanced software, integrated controller solutions, wireless communication modules, and comprehensive field services. Its flagship platform, SmartTrace, is a robust solution available in both cloud-based and on-premises deployments that enables predictive maintenance, minimizes downtime, and provides secure remote monitoring—helping customers achieve greater reliability and operational efficiency. This endeavor will help Chemelex support greater operational efficiencies for our cus

ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA6.1.2026 20:30:00 EET | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced full results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), a HER2-targeted bispecific antibody, in combination with chemotherapy, with and without PD-1 inhibitor TEVIMBRA® (tislelizumab), as a first-line treatment for HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). These data, including the first interim overall survival (OS) analysis, will be presented as a Late-Breaking Abstract Oral Presentation (#LBA285) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) on January 8, 2026, from 8:57- 9:07 a.m. PST. HERIZON-GEA-01 met the dual primary endpoint of progression-free survival (PFS), demonstrating statistically significant and clinically meaningful improvements in both experimental arms compared to the control arm. The addition of TEVIMBRA to ZIIHERA and chemotherapy also sho

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye